X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ALKEM LABORATORIES - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ALKEM LABORATORIES CADILA HEALTHCARE/
ALKEM LABORATORIES
 
P/E (TTM) x 33.5 - - View Chart
P/BV x 6.2 7.5 83.1% View Chart
Dividend Yield % 0.8 0.6 130.7%  

Financials

 CADILA HEALTHCARE   ALKEM LABORATORIES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
ALKEM LABORATORIES
Mar-16
CADILA HEALTHCARE/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4601,589 28.9%   
Low Rs3051,232 24.8%   
Sales per share (Unadj.) Rs92.1417.5 22.1%  
Earnings per share (Unadj.) Rs14.856.3 26.3%  
Cash flow per share (Unadj.) Rs18.564.7 28.6%  
Dividends per share (Unadj.) Rs3.2012.70 25.2%  
Dividend yield (eoy) %0.80.9 92.9%  
Book value per share (Unadj.) Rs68.0292.9 23.2%  
Shares outstanding (eoy) m1,023.74119.57 856.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.23.4 122.9%   
Avg P/E ratio x25.825.1 103.0%  
P/CF ratio (eoy) x20.721.8 95.0%  
Price / Book Value ratio x5.64.8 116.8%  
Dividend payout %21.622.6 95.7%   
Avg Mkt Cap Rs m391,581168,653 232.2%   
No. of employees `00016.9NA-   
Total wages/salary Rs m15,0029,171 163.6%   
Avg. sales/employee Rs Th5,594.5NM-  
Avg. wages/employee Rs Th890.1NM-  
Avg. net profit/employee Rs Th899.9NM-  
INCOME DATA
Net Sales Rs m94,29549,915 188.9%  
Other income Rs m1,2861,645 78.2%   
Total revenues Rs m95,58151,561 185.4%   
Gross profit Rs m19,0368,482 224.4%  
Depreciation Rs m3,7501,006 372.8%   
Interest Rs m450671 67.1%   
Profit before tax Rs m16,1228,451 190.8%   
Minority Interest Rs m338-114 -297.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,2891,606 80.3%   
Profit after tax Rs m15,1686,731 225.3%  
Gross profit margin %20.217.0 118.8%  
Effective tax rate %8.019.0 42.1%   
Net profit margin %16.113.5 119.3%  
BALANCE SHEET DATA
Current assets Rs m60,22327,062 222.5%   
Current liabilities Rs m53,05815,324 346.3%   
Net working cap to sales %7.623.5 32.3%  
Current ratio x1.11.8 64.3%  
Inventory Days Days7067 105.0%  
Debtors Days Days8841 213.6%  
Net fixed assets Rs m72,98412,610 578.8%   
Share capital Rs m1,024239 428.3%   
"Free" reserves Rs m68,57634,490 198.8%   
Net worth Rs m69,60035,027 198.7%   
Long term debt Rs m24,6841,212 2,037.3%   
Total assets Rs m152,20754,387 279.9%  
Interest coverage x36.813.6 270.7%   
Debt to equity ratio x0.40 1,025.3%  
Sales to assets ratio x0.60.9 67.5%   
Return on assets %10.313.6 75.4%  
Return on equity %21.819.2 113.4%  
Return on capital %17.924.9 72.1%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m21,2806,563 324.2%   
Fx outflow Rs m10,8743,012 361.1%   
Net fx Rs m10,4063,552 293.0%   
CASH FLOW
From Operations Rs m13,4957,259 185.9%  
From Investments Rs m-29,1031,864 -1,561.2%  
From Financial Activity Rs m23,158-9,273 -249.7%  
Net Cashflow Rs m7,556-150 -5,037.3%  

Share Holding

Indian Promoters % 74.8 66.9 111.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 33.1 25.1%  
FIIs % 5.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 0.0 -  
Shareholders   44,069 68,381 64.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NATCO PHARMA  PLETHICO PHARMA  FDC LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Idea Plunges 5% on Weak Q3 Peformance(Closing)

Indian share markets finished on a flat note after a five-session record-setting spree as profit booking was witnessed in metal stocks, capital goods stocks.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 24, 2018 03:33 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS